Titan Pharmaceuticals, Inc.
TTNP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,706 | -$5,569 | -$10,206 | -$8,776 |
| Dep. & Amort. | $5 | $112 | $196 | $221 |
| Deferred Tax | $0 | $0 | $0 | -$661 |
| Stock-Based Comp. | $0 | $1,013 | $997 | $1,505 |
| Change in WC | $823 | -$916 | $378 | -$219 |
| Other Non-Cash | -$2 | -$1,732 | $452 | -$5 |
| Operating Cash Flow | -$3,880 | -$7,092 | -$8,183 | -$7,899 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2 | $0 | -$23 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $734 | $0 | -$23 |
| Investing Cash Flow | $0 | $732 | $0 | -$23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $500 | $0 | $0 |
| Stock Issued | $0 | $9,500 | $4,980 | $8,841 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$62 | $9,500 | $4 | $0 |
| Financing Cash Flow | -$62 | $10,000 | $4,984 | $8,841 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,942 | $3,640 | -$3,199 | $919 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,773 | $3,133 | $6,332 | $5,413 |
| End Cash | $2,831 | $6,773 | $3,133 | $6,332 |
| Free Cash Flow | -$3,880 | -$7,094 | -$8,183 | -$7,922 |